A comparative investigation of anti-Müllerian hormone (AMH) and various biochemical parameters in patients with cryptorchidism, oligospermia, or varicocele;Kriptorşit, oligospermi ve varikoselli hastalarda anti-müllerian hormon (AMH) ve farklı biyokimyasal parametrelerin karşılaştırılması

Turkish Journal of Medical Sciences

Volumn 42, Issue 3, 2012, Pages 411-415

  Akdaǧ, Turan ^a   TIftik, Ali Muhtar ^a   Sariyildiz, Levent ^b  

^a SELCUK UNIVERSITY   (Turkey)

^b Section of Pediatric Surgery   (Turkey)

Author keywords

Anti M llerian hormone; Cryptorchidism; Infertility; Varicocele

Indexed keywords

FOLLITROPIN; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR; PROLACTIN; TESTOSTERONE;

ADULT; ARTICLE; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; CRYPTORCHISM; FOLLITROPIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OLIGOSPERMIA; PROLACTIN BLOOD LEVEL; SCHOOL CHILD; VARICOCELE;

EID: 84859763221     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: 10.3906/sag-1101-1467     Document Type: Article

References (28)

1. Massague J. The transforming growth factor-beta family. Annu Rev Cell Biol 1990; 6: 597-641.
2. Rajpert-De ME, Jorgensen N, Graem N, Müller J, Cate RL, Skakkebaek NE. Expression of anti-Müllerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab 1999; 84: 3836-3844.
3. Rodolfo R. Anti-Müllerian hormone in disorders of sex determination and differentiation. Arq Bras Endocrinol Metab 2005; 49: 26-36.
4. AH Lane, PK Donahoe. New insights into Mullerian inhibiting substance and its mechanism of action. J Endocrinol 1998; 158: 1-6.
5. Kumar A, Karla B, Patel A, McDavid L, Roudebush WE. Development of a second generation Anti-Müllerian hormone (AMH) ELISA. J Immunol Methods 2010; 362: 51-59.
6. Al-Qahtani A, Muttukrishna S, Appasamy M, Johns J, Cranfield M, Visser JA et al. Development of a sensitive enzyme immunoassay for anti-Müllerian hormone and the evaluation of potential clinical applications in males and females. Clin Endocrinol 2005; 63: 267-273.
7. Grinspon RP, Rey RA. Anti-müllerian hormone and sertoli cell function in pediatric male hypogonadism. Horm Res Paediatr 2010; 73: 81-92.
8. Josso N, Racine C, di Clemente N, Rey R, Xavier F. The role of anti-Müllerian hormone in gonadal development. Mol Cell Endocrinol 1998; 145: 3-7.
9. Griffin JE, Ojeda S. Textbook of Endocrinology. New York: Oxford University Press; 1988.
10. Goodman MH. Basic Medical Endocrinology. 3rd ed. USA: Elsevier Science; 1988.
11. Serge N, Luis FP. Hormones in male sexual development. Genes Dev 2000; 14: 3075-3086.
12. Aksglaede L, Sørensen K, Boas M, Mouritsen A, Hagen C, Jensen R et al. Changes in Anti-Müllerian Hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. J Clin Endocrinol & Metabol 2010; 95: 5357-5364.
13. Josso N, Boussin L, Knebelmann B, Nihoul-Fékété C, Picard JY. Anti-Müllerian hormone and intersex states. Trends Endocrinol Metabol 1991; 2: 227-233.
14. Josso N, Racine C, di Clemente N, Rey R, Xavie r F. The role of anti-Müllerian hormone in gonadal development. Mol Cell Endocrinol 1998; 145: 1-2.
15. World Health Organization. Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interaction. 4th ed. New York: Cambridge University Press; 1999.
16. Wackerly D, Mendenhall W, Scheaffer RL. Mathematical Statistics with Applications. USA: Thomson Learn; 2002.
17. Lee MM, Misra M, Donahoe PK, MacLaughlin DT. MIS/AMH in the assessment of cryptorchidism and intersex conditions. Mol Cell Endocrinol 2003; 211: 91-8.
18. Demircan M, Akinci A, Mutus M. The effects of orchiopexy on serum anti-Müllerian hormone levels in unilateral cryptorchid infants. Pediatr Surg Int 2006; 22: 271-3.
19. Rey R, Lordereau-Richard I, Carel JC, Barbet P, Cate RL, Roger M et al. Anti-Müllerian hormone and testosterone serum levels are inversely during normal and precocious pubertal development. J Clin Endocrinol Metab 1993; 77: 1220-6.
20. Yamanaka J, Baker M, Metcalfe S, Hutson JM. Serum levels of Mullerian inhibiting substance in boys with cryptorchidism. J Pediatr Surg 1991; 26: 621-3.
21. Najiba L, Ilene F, Jean-Claude C, Marc R. Inhibin B and Anti-Müllerian hormone, but not testosterone levels, are normal in infants with nonmosaic Klinefelter syndrome. J Clin Endocrinol & Metabol 2004: 89; 1864-1868.
22. Baker ML, Metcalfe SA, Hutson JM. Serum levels of Müllerian inhibiting substance in boys from birth to 18 years, as determined by enzyme immunoassay. J Clin Endocrinol Metabol 1990; 70: 11-5.
23. Trigo RV, Bergadá I, Rey R, Ballerini MG, Bedecarrás P, Bergadá C et al. Altered serum profile of inhibin B, Pro-alpha C and anti-Müllerian hormone in prepubertal and pubertal boys with varicocele. Clin Endocrinol 2004; 60: 758-64.
24. Pierik FH, Burdorf A, de Jong FH, Weber RF. Inhibin B: a novel marker of spermatogenesis. Ann Med 2003; 35: 12-20.
25. V Sriraman, E. Niu, JR Matias, PK. Donahoe, DT MacLaughlin, MP Hardy et al. Müllerian inhibiting substance inhibits testosterone synthesis in adult rats. J Androl 2001; 22: 750-8.
26. Salhi I, Cambon-Roques S, Lamarre I, Laune D, Molina F, Pugnière M et al. The anti-Müllerian hormone type II receptor: insights into the binding domains recognized by a monoclonal antibody and the natural ligand. Biochem J 2004; 379: 785-93.
27. Kevenaar ME, Themmen AP, Rivadeneira F, Uitterlinden AG, Laven JS, van Schoor NM et al. A polymorphism in the AMH type II receptor gene is associated with age at menopause in interaction with parity. Hum Reprod 2007; 22: 2382-8.
28. Bédécarrats GY, O'Neill FH, Norwitz ER, Kaiser UB, Teixeira J. Regulation of gonadotropin gene expression by Mullerian inhibiting substance. Proc Natl Acad Sci USA 2003; 100: 9348-53.